On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayMar 17, 2021 11:38 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Advances Psychedelic IND Candidates, Announces Completion of 20th Preclinical Study

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced completion of its 20th preclinical study and is progressing its CYB003 and CYB004 proprietary psychedelic molecules into Investigational New Drug (“IND”)-enabling studies. According to the update, Cybin, through collaboration with its partners and contractors, has completed key research studies both in-vitro and in-vivo. Based on proprietary Cybin technologies, more than 20 definitive research studies designed by the company’s scientists were completed in record time. “Excellent teamwork and fully supportive partners have greatly facilitated the advancement of these two new therapeutic candidates with enhanced and improved…

Continue Reading

WednesdayMar 17, 2021 11:25 am

NetworkNewsBreaks – Friendable Inc. (FDBL) Mid-Month Update Indicates Impressive Growth

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, is seeing a significant increase in artists enrolling in its exclusive Fan Pass program, which is a live-streaming platform. The company also notes an impressive uptick in social media activity on the platform as well. Ten artists have joined the Fan Pass platform so far this month, which beats February numbers — and the month is only halfway over. In addition, the company noted that social media indicators show Fan Pass’ Facebook reach is up 96%, post engagements are…

Continue Reading

WednesdayMar 17, 2021 10:51 am

NetworkNewsBreaks – Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) Secures Conditional Approval for TSX Listing

Augusta Gold (CSE: G) (OTCQB: AUGG) (FSE: 11B) today announced its receipt of conditional approval to list its common shares on the Toronto Stock Exchange (the "TSX"). Concurrent with the TSX listing, Augusta Gold’s common shares will be de-listed from the Canadian Securities Exchange. Augusta Gold's trading symbol will remain "G" on the TSX. Final approval of the listing is subject to Augusta Gold meeting certain customary conditions required by the TSX. The company will issue an update upon confirmation on the effective date for commencement of trading of Augusta Gold common shares on the TSX. "We are very pleased…

Continue Reading

WednesdayMar 17, 2021 10:35 am

NetworkNewsBreaks – WELL Health Technologies Corp. (TSX: WELL) Releases Management Update, Announces Seed Investment

WELL Health Technologies (TSX: WELL), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, has made to new appointment to its leadership team. The company named Atoussa Mahmoudpour as its chief legal officer and Ammar Shah as its vice president of mergers and acquisitions (“M&A”). Mahmoudpour has been serving as WELL’s vice president of legal affairs and compliance since September 2020; before coming to WELL, she held senior positions at several leading international firms, including Eversheds Sutherland LLP. Shah also joined the WELL team last September as director of M&A; his prior experience included serving as…

Continue Reading

WednesdayMar 17, 2021 10:31 am

NetworkNewsBreaks – MRVL Pet Pharmaceuticals(TM) Corp. to Collaborate with Altran for FDA Clinical Trials on Canine and Feline Cancer and Arthritis Treatment Products

MRVL Pet Pharmaceuticals(TM), a life sciences and technology company focused on the animal health sector, today announced its entry into an agreement with the Life Sciences division of Altran, a Capgemini company, to provide advisory services on their U.S. FDA clinical trial process for canine and feline cancer and arthritis products. According to the update, renowned veterinary expert Dr. Albert Ahn was appointed as the chief researcher of the clinical trial that launched on Jan. 27, 2021, and is expected to consist of three phases and run until Dec. 30, 2022. Altran’s AVP of Regulatory Affairs, Quality and Compliance, Deborah…

Continue Reading

WednesdayMar 17, 2021 10:23 am

NetworkNewsBreaks – Knightscope Inc. Announces Another Crime-Fighting Win

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today provided an update on another crime-fighting win to add to its long list of successes (see www.Knightscope.com/Crime for others). An article published by the Las Vegas Review-Journal discusses the Knightscope MIN31KS, the human-sized autonomous robot that patrols a Las Vegas apartment complex, offering a wide variety of security measures. These include four-camera video recording, facial recognition, license plate reading, verbal warnings, a telephone-like connection with human security officers, as well as a presence that helps deter improper activity. “It’s been very useful in several ways,”…

Continue Reading

WednesdayMar 17, 2021 10:09 am

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Announces Official Launch of hearIQ App

InnerScope Hearing Technologies (OTC: INND) today officially announced the launch of its hearIQ App in 172 countries in the Apple App Store for iOS devices and Google Play Store for Android devices. The hearIQ App is a multi-functional solution, which offers to the general public a FREE self-administered hearing test to determine hearing loss (if any) and also provides a Bluetooth wireless connection for InnerScope's direct-to-consumer self-fitting-self-adjusting hearing aids. The hearIQ App is specifically designed to help with early detection of hearing loss for the 48+ million Americans as well as the 1.5 billion people worldwide who, according to the…

Continue Reading

WednesdayMar 17, 2021 10:07 am

NetworkNewsBreaks – Torchlight Energy Resources Inc. (NASDAQ: TRCH) Secures $27M in Underwritten Public Offering

Torchlight Energy (NASDAQ: TRCH), an oil and gas exploration company, has closed an underwritten public offering of 23,000,000 shares of its common stock, including an additional 3,000,000 shares pursuant to the full exercise of the over-allotment option granted to the underwriters. Torchlight Energy secured approximately $27.6 million in gross proceeds, with each of the shares sold at the public offering price of $1.20. The company intends to use the proceeds for general business purposes and to provide $5 million of additional bridge financing to Metamaterial Inc. in connection with the previously announced agreement under which the companies will complete a…

Continue Reading

WednesdayMar 17, 2021 9:50 am

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Subsidiary Has Ordered First Shipment of Functional Mushrooms

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) subsidiary Pure Mushrooms Corp. has placed its first order for functional mushrooms from a British Columbia co-packer. Pure Mushrooms will use the mushrooms to produce three products, which will be offered through the company’s online e-commerce store. Previously Pure Mushrooms had developed three premium formulations based on reishi, maitake and lion’s mane mushrooms. These formulations, which are delivered in convenient vegan capsules, will be the foundation of the upcoming new products. Rreishi and maitake formulations should go on sale in April, with the  lion’s mane release slated for June. The announcement…

Continue Reading

WednesdayMar 17, 2021 9:33 am

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Collaboration with JelikaLite

Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, recently announced a collaboration with JelikaLite, a company developing Cognilum(TM), a non-invasive wearable photobiomodulation device that is being developed to increase the well-being of children living with autism, through a clinical trial. In the trial, “Transcranial Photobiomodulation for Reducing Autism Symptoms in Children,” brain treatments for children diagnosed with autism would be delivered through Cognilum, while Brain Scientific’s NeuroEEG, a wireless EEG device, will monitor brain activity. The trial is designed to provide researchers and clinicians an opportunity to potentially uncover new treatment options for reducing the symptoms…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217